Literature DB >> 8707299

Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation.

H Ozcelik1, Y J Antebi, D E Cole, I L Andrulis.   

Abstract

We describe a heteroduplex analysis for the detection of the 185delAG mutation in the BRCA1 gene. The protein truncation test (PTT) has previously been used to identify many of the mutations in BRCA1 that result in premature termination of the protein. However, we were not able to detect the 185delAG mutation by PTT and suggest that heteroduplex analysis may complement PTT for analysis of BRCA1 mutations. This simple technique may be useful for studies on the prevalence and the penetrance of the 185delAG mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707299     DOI: 10.1007/s004390050212

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary- and microchip-based electrophoresis.

Authors:  H Tian; L C Brody; J P Landers
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

2.  Detection of false positive mutations in BRCA gene by next generation sequencing.

Authors:  Moushumi Suryavanshi; Dushyant Kumar; Manoj Kumar Panigrahi; Meenakshi Chowdhary; Anurag Mehta
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

3.  Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry.

Authors:  Anna Marie Mulligan; Irene Raitman; Linda Feeley; Dushanthi Pinnaduwage; Linh T Nguyen; Frances P O'Malley; Pamela S Ohashi; Irene L Andrulis
Journal:  Clin Cancer Res       Date:  2012-12-04       Impact factor: 12.531

4.  Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications.

Authors:  T Pal; N Hamel; D Vesprini; K Sanders; M Mitchell; N Quercia; N Ng Cheong; A Murray; W Foulkes; S A Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

5.  BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.

Authors:  H Yazici; O Bitisik; E Akisik; N Cabioglu; P Saip; M Muslumanoglu; G Glendon; E Bengisu; S Ozbilen; M Dincer; S Turkmen; I L Andrulis; N Dalay; H Ozcelik
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.